Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilya Kister

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 5, 2017
Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - YESIlya Kister
Current Neurology and Neuroscience Reports|September 19, 2025
Paroxysmal Neurology: a Guide to Diagnosing Transient Neurologic Dysfunction in Adults and AdolescentsIlya Kister
Current Allergy and Asthma Reports|May 12, 2016
Common and Rare Manifestations of Neuromyelitis Optica Spectrum DisorderDominique Rosales, Ilya Kister
Neurology|March 22, 2017
Author response: Reducing costs while enhancing quality of care in MSIlya Kister, John Corboy
Frontiers in Neurology|October 5, 2020
The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and AdultsErica Parrotta, Ilya Kister
Frontiers in Chemistry|March 10, 2023
Overview of myelin, major myelin lipids, and myelin-associated proteinsAlexander Kister, Ilya Kister
Neurology|June 21, 2015
Pushing the boundaries of neuromyelitis optica: does antibody make the disease?Ilya Kister, Friedemann Paul
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
Multiple Sclerosis Severity Score: Concept and applicationsIlya Kister, Orhun H Kantarci
Current Neurology and Neuroscience Reports|May 19, 2021
Infection Mitigation Strategies for Multiple Sclerosis Patients on Oral and Monoclonal Disease-Modifying TherapiesTyler Ellis Smith, Ilya Kister
Neurology|September 4, 2016
Reducing costs while enhancing quality of care in MSIlya Kister, John R Corboy
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 5, 2017
Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - YESIlya Kister
Current Neurology and Neuroscience Reports|September 19, 2025
Paroxysmal Neurology: a Guide to Diagnosing Transient Neurologic Dysfunction in Adults and AdolescentsIlya Kister
Current Allergy and Asthma Reports|May 12, 2016
Common and Rare Manifestations of Neuromyelitis Optica Spectrum DisorderDominique Rosales, Ilya Kister
Neurology|March 22, 2017
Author response: Reducing costs while enhancing quality of care in MSIlya Kister, John Corboy
Frontiers in Neurology|October 5, 2020
The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and AdultsErica Parrotta, Ilya Kister
Frontiers in Chemistry|March 10, 2023
Overview of myelin, major myelin lipids, and myelin-associated proteinsAlexander Kister, Ilya Kister
Neurology|June 21, 2015
Pushing the boundaries of neuromyelitis optica: does antibody make the disease?Ilya Kister, Friedemann Paul
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2020
Multiple Sclerosis Severity Score: Concept and applicationsIlya Kister, Orhun H Kantarci
Current Neurology and Neuroscience Reports|May 19, 2021
Infection Mitigation Strategies for Multiple Sclerosis Patients on Oral and Monoclonal Disease-Modifying TherapiesTyler Ellis Smith, Ilya Kister
Neurology|September 4, 2016
Reducing costs while enhancing quality of care in MSIlya Kister, John R Corboy
Pageof 13